Merck (MRK) Tops Q3 EPS by 4c; Lifts FY15 EPS Outlook

October 27, 2015 6:47 AM EDT

Merck (NYSE: MRK) reported Q3 EPS of $0.96, $0.04 better than the analyst estimate of $0.92. Revenue for the quarter came in at $10.1 billion versus the consensus estimate of $10.11 billion.

Merck sees FY2015 EPS of $3.55-$3.60, versus prior guidance of $3.45-$3.55 and the consensus of $3.51.

For earnings history and earnings-related data on Merck (MRK) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance, Hot Earnings, Hot Guidance

Related Entities